2013-11-14T09:17:38-06:00 2012-12-31 PricewaterhouseCoopers LLP 1301 K STREET NW SUITE 800W WASHINGTON DC 200053333 990 2012-01-01 201512696 BIONEXUS FOUNDATION % GREGORY J FORTON BION 7033652700 10801 UNIVERSITY BOULEVARD Suite MANASSAS VA 201102209 GREGORY J FORTON 7033652716 2013-11-14 true 2024141000 2012 2016-02-24 21:20:13Z RAYMOND H CYPESS 10801 UNIVERSITY BOULEVARD MANASSAS VA 201102209 51153613 false X WWW.ATCC.ORG X 2004 DC BIONEXUS IS ORGANIZED TO OPERATE EXCLUSIVELY FOR CHARITABLE, EDUCATIONAL, SCIENTIFIC, AND LITERARY PURPOSES; TO SUPPORT THE EDUCATIONAL AND SCIENTIFIC MISSION OF THE ATCC. 4 3 0 0 0 0 0 5000000 0 0 1540399 3407847 0 0 1540399 8407847 0 0 0 0 0 447959 0 0 0 228012 1026972 228012 1474931 1312387 6932916 49120211 58045290 36393 1180623 49083818 56864667 X BIONEXUS IS ORGANIZED TO OPERATE EXCLUSIVELY FOR CHARITABLE, EDUCATIONAL, SCIENTIFIC, AND LITERARY PURPOSES, WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (OR CORRESPONDING PROVISIONS OF ANY SUBSEQUENT FEDERAL TAX LAWS); WITHIN SUCH LIMITS, TO SUPPORT THE EDUCATIONAL AND SCIENTIFIC MISSION OF THE AMERICAN TYPE CULTURE COLLECTION. true false 0 0 0 SEE ATTACHMENT 1 0 true true false false false false false false false false false false false false true false false true false false false false false false false false false false false true false false false false false false false false false false false false false true false false false true 0 0 0 false false false false false false false false false false false X 4 3 false false false false true true true true true false false true true true true true true false false false VA X GREGORY J FORTON 7033652717 10801 UNIVERSITY BOULEVARD MANASSAS VA 201102209 RAYMOND H CYPESS 0.6 38.7 X X 0 1063983 133667 JOHN L CHILD JR 0.6 1.2 X X 0 19000 0 ELLIOT M LEVINE 0.6 0.0 X 0 3500 0 DIANE E GRIFFIN 0.6 1.2 X 0 18750 0 LEONARD P FREEDMAN 37.5 1.8 X 0 78185 7449 FRANK P SIMIONE 0.6 37.5 X 0 124773 12942 WILBUR M PRIESTER 0.6 38.7 X 0 304495 61985 0 1612686 216043 0 false true false BROWN ADVISORY 901 SOUTH BOND STREET SUITE 400 BALTIMORE MD 212313340 INVESTMENT ADVISORY 280440 FEINSTEIN KEAN HEALTHCARE OGLIVY PUBLIC REL WORLDWIDE PO BOX PHILADELPHIA PA 191707417 BUSINESS CONSULTING 160830 2 5000000 5000000 0 1202243 1202243 0 0 0 0 0 44951370 42745766 2205604 2205604 2205604 0 0 0 0 8407847 0 0 3407847 0 0 0 0 0 0 352149 352149 0 95810 95810 0 0 12755 12755 0 0 0 280440 280440 172450 172450 0 155800 155800 0 0 227931 227931 2456 2456 0 664 664 0 0 0 0 NON-CONTRACTED SERVICES 18461 18461 RECRUITMENT 127700 127700 OTHER INVESTMENT EXPENSES 28315 28315 1474931 0 1474931 0 0 0 1119220 876982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 45306641 54622022 2661108 2513044 0 0 0 0 33242 33242 49120211 58045290 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 36393 1180623 36393 1180623 X 49083818 56864667 0 0 0 0 49083818 56864667 49120211 58045290 6932916 847933 X false true X true false X X X false false false AMERICAN TYPE CULTURE COLLECTION 530196548 03 true 0 1 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 DUE TO ATCC 1180623 1180623 false false false false true false true false false RAYMOND H CYPESS 0 673335 0 308644 0 82004 0 121882 0 11785 0 1197650 0 83644 WILBUR M PRIESTER 0 251906 0 51576 0 1013 0 39337 0 22648 0 366480 0 26657 PART I, LINE 3: BIONEXUS FOUNDATION DOES NOT COMPENSATE ANY DIRECTOR, OFFICER, OR EMPLOYEE. COMPENSATION TO THESE INDIVIDUALS IS PROVIDED BY A RELATED, SUPPORTED ORGANIZATION. THE COMPENSATION COMMITTEE OF THE RELATED ORGANIZATION'S BOARD OF DIRECTORS REVIEWS RECOMMENDATIONS BY THE CEO OF THE RELATED ORGANIZATION AND GIVES FINAL APPROVAL FOR THE COMPENSATION PROGRAMS TO INCLUDE MARKET AND RANGE ADJUSTMENTS, MERIT INCREASES, BONUSES AND BENEFITS. A THIRD PARTY ANALYSIS OF TOTAL EXECUTIVE COMPENSATION WAS CONDUCTED FOR CALENDAR YEAR 2011 COMPENSATION, AND A SIMILAR ANALYSIS FOR THE REST OF THE EXECUTIVE TEAM WILL BE COMPLETED IN 2014. THE COMPENSATION COMMITTEE REVIEWS AND APPROVES COMPENSATION FOR THE CEO USING DATA FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS WITHIN SIMILAR INDUSTRIES. DOCUMENTATION OF SUCH DISCUSSIONS AND DECISIONS ARE CAPTURED IN THE MEETING MINUTES. PART I, LINE 5B & 6B: ATCC, A RELATED ORGANIZATION AND THE COMMON PAYMASTER FOR BIONEXUS FOUNDATION, ESTABLISHED A LONG-TERM INCENTIVE PROGRAM, EFFECTIVE JANUARY 1, 2007, TO ATTRACT AND RETAIN KEY EMPLOYEES AND SENIOR EXECUTIVES. THE PROGRAM IS DESIGNED TO PROVIDE CASH BONUSES TO EXECUTIVES AND SENIOR MANAGEMENT OF ATCC WHO HELP THE ORGANIZATION ACHIEVE FINANCIAL AND STRATEGIC GOALS. SUCH LONG-TERM COMPENSATION IS IN ALIGNMENT WITH THE MARKETPLACE. AWARD AMOUNTS ARE CALCULATED BASED ON A PRE-DETERMINED FORMULA TAKING INTO ACCOUNT ATCC'S REVENUES AND NET-EARNINGS. PAYMENT OF THE AWARDS IS MADE THREE YEARS AFTER THE AWARD IS EARNED AND IS MADE COMPLETELY AT THE DISCRETION OF THE BOARD OF DIRECTORS OF ATCC. DURING THE THREE-YEAR ACCRUAL PERIOD, THESE BONUSES ARE REPORTED AS DEFERRED COMPENSATION ON SCHEDULE J, PART II, COLUMN (C). IN 2012, ACTUAL PAYMENTS WERE MADE FOR 2009 PERFORMANCE BONUSES AND ARE REPORTED ON BOTH SCHEDULE J, PART II, COLUMN B AS FORM W-2 WAGES AND SCHEDULE J, PART II, COLUMN (F). PART III, LINE 2: BIONEXUS IS CURRENTLY FUNDING A PROGRAM (GBSI) DEDICATED TO ADVANCING LIFE SCIENCE STANDARDS THROUGH POLICY INITIATIVES, THOUGHT LEADERSHIP, AND EDUCATION. THE PROGRAM IS DEDICATED TO ADVANCING LIFE SCIENCE STANDARDS ACROSS THE SPECTRUM OF BIOLOGICAL SCIENCES IN ORDER TO IMPROVE HUMAN HEALTH. FIVE BROAD AREAS TO PURSUE THROUGH THE DEVELOPMENT OF STANDARDS INCLUDE BASIC BIOLOGICAL RESEARCH (BBR), TRANSLATIONAL AND REGULATORY (T&R), FOOD AND WATER SAFETY (FWS), BIODEFENSE AND EMERGING INFECTIONS (BD & EI), AND ENABLING TECHNOLOGIES (ET). PART VI, LINES 6, 7A, & 7B: BIONEXUS FOUNDATION ("BIONEXUS") IS A CORPORATION ESTABLISHED UNDER THE DISTRICT OF COLUMBIA NON-PROFIT CORPORATION ACT. IT HAS ONE CORPORATE MEMBER, ATCC GLOBAL, WHICH IS TAX EXEMPT UNDER 501(C)(3) AND IS A TYPE II SUPPORTING ORGANIZATION UNDER 509(A)(3). ATCC GLOBAL HAS THE RIGHT TO ELECT BIONEXUS' BOARD OF DIRECTORS AND TO VOTE IN ANY CORPORATE PROCEEDING WHICH IS SUBMITTED TO A VOTE OF THE CORPORATE MEMBERSHIP. BIONEXUS' BOARD OF DIRECTORS HAS THE AUTHORITY TO MANAGE THE BUSINESS AND DO ALL SUCH LAWFUL ACTS AND THINGS AS ARE NOT PROHIBITED BY STATUTE OR BY THE ARTICLES OF INCORPORATION OR BIONEXUS' BYLAWS. ANY MODIFICATIONS TO THE ARTICLES OF INCORPORATION OR BYLAWS REQUIRE THE APPROVAL OF ATCC GLOBAL. PART VI, LINE 11B: THE FORM 990 IS PREPARED BY PRICEWATERHOUSECOOPERS LLP ("PWC"), BASED ON THE INFORMATION PROVIDED BY THE ORGANIZATION'S STAFF. THE BOARD OF DIRECTORS HAS DELEGATED THE REVIEW OF THE FORM 990 TO THE FINANCE AND AUDIT COMMITTEE. PRIOR TO FILING WITH THE IRS, THE FORM 990 IS MAILED TO THE FINANCE AND AUDIT COMMITTEE. ONCE THE FORM 990 IS REVIEWED BY THE COMMITTEE AND IS MADE AVAILABLE TO THE BOARD, PWC SIGNS AS PREPARER AND THE CHIEF FINANCIAL OFFICER SIGNS ON BEHALF OF THE ORGANIZATION. PART VI, LINE 12C: BIONEXUS HAS A CONFLICT OF INTEREST POLICY THAT REQUIRES OFFICERS AND DIRECTORS TO DISCLOSE ANNUALLY, INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THIS POLICY IS CONSISTENTLY MONITORED AND ENFORCED. BOARD MEMBERS WHO HAVE A CONFLICT OF INTEREST DO NOT VOTE ON ANY MATTER RELATED TO THE ISSUE FOR WHICH THEY HAVE A POTENTIAL CONFLICT. PART VI, LINE 19: THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY OR FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. OTHER FEES FOR SERVICES FOR NON-EMPLOYEES FORM 990 PART IX LINE 11G DESCRIPTION:FEINSTEIN KEAN HEALTHCARE TOTAL FEES:160830 OTHER FEES FOR SERVICES FOR NON-EMPLOYEES FORM 990 PART IX LINE 11G DESCRIPTION:OTHER CONSULTANTS TOTAL FEES:11620 AMERICAN TYPE CULTURE COLLECTION 10801 UNIVERSITY BOULEVARD MANASSAS VA 20110 530196548 SCIENCE RSRCH DC 501(C)(3) 7 ATCC GLOBAL false ATCC GLOBAL 10801 UNIVERSITY BOULEVARD MANASSAS VA 20110 753159126 SUPPORT ATCC DC 501(C)(3) 11- TYPE II NA false ATCC CELL SYSTEMS INC 10801 UNIVERSITY BOULEVARD MANASSAS VA 201102209 541805129 LAB SERVICES VA ATCC GLOBAL C CORP 0.00000 false false false true false false false false false false false false false true true true false false false